Inozyme Pharma Overview

Inozyme Pharma Operating Income

Operating Income for INZY.

Quarterly Operating Income

$-27688000.00

↑ 13.73% YoY

As of Mar 31, 2025

Annual Operating Income (TTM)

$-107375000.00

↑ 31.55% YoY

Trailing 12 months ending Mar 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin